During 2016 through 2018, inpatient stays for alcohol-related disorders were concentrated in the Midwest, parts of Appalachia, Nevada and Rhode Island, while stays for opioid-related disorders were concentrated in Appalachia and New Jersey.
An AHRQ Healthcare Cost and Utilization Project (HCUP) Statistical Brief – #289 Geographic Variation in Inpatient Stays for Five Leading Substance Use Disorders, 2016-2018 – found that state rates of inpatient stays for the five leading substance use disorders (SUDs) varied across the 38 States included in this Statistical Brief.
The Statistical Brief presents 3-year aggregate statistics on national, State, and substate regional variation in inpatient stays for SUDs among patients of all ages at community hospitals (excluding rehabilitation and long-term care hospitals) using the 2016-2018 National Inpatient Sample (NIS) and the 2016-2018 State Inpatient Databases (SID). Geographic areas are based on the patient ZIP Code of residence. The Brief focused on the five leading SUD principal diagnoses for inpatient stays in the United States: alcohol-related disorders, opioid-related disorders, stimulant-related disorders, sedative-related disorders, and cannabis-related disorders. Statistics are presented for 38 States that, at the time this Statistical Brief was written, had released aggregate 2016-2018 data through the Community-Level Statistics path of HCUPnet, an online query tool for county- and substate region-level statistics. These States represented 80 percent of the U.S. population in 2018.